🫀21st ACC.25 Congress Coverage: SGLT2 Inhibitors Progressing to New Standard After TAVI, DapaTAVI Trial, by Dr. Tahamtan, Fellowship of Electrophysiology.
🔸Stay tuned for more insights from the late-breaking trials presented during this magnificent scientific event.
اولین نفر کامنت بزار
🫀20th ...
19th ACC 2025 Congress Coverage: HPV Infection ...
18th ACC 2025 Congress Coverage: SOUL Trial
💊 Hype...
تمامی حقوق این وبسایت متعلق به شنوتو است